Evidence map›Paper›PMID 41843178›Full record

ArticleJournal of molecular modeling2026

Resonant terahertz-induced stark field disruption of fentanyl's μ-opioid receptor binding for precision overdose reversal.

Moses Udoisoh, Olusola Olaitan Adegoke, Stephen Nartey Adamtey, Joseph Gyutorwa Samson

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Moses UdoisohNanophotonics and Solid-State Physics Unit, Department of Physics, Ignatius Ajuru University of Education, Rumuolumeni, Rivers State, Nigeria. moses.udoisoh@iaue.edu.ng.
Olusola Olaitan AdegokeDepartment of Biochemistry, Joseph Ayo Babalola, University, Ikeji-Arakeji, Osun State, Nigeria.
Stephen Nartey AdamteyDepartment of Biomedical Sciences, University of Cape Coast, Cape Coast, Ghana.
Joseph Gyutorwa SamsonDepartment of Biological Sciences, Kaduna State University, Kaduna, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe opioid overdose crisis, driven by synthetic opioids like fentanyl, demands a paradigm shift beyond conventional pharmacology. Fentanyl's lethality stems from its sub-nanomolar affinity and ultra-slow dissociation kinetics from the μ-opioid receptor (μOR), which render competitive antagonists like naloxone increasingly ineffective. This critical limitation necessitates a physics-based strategy capable of directly disrupting the molecular bonds anchoring fentanyl within the receptor's binding pocket.

methodWe develop a quantum-mechanical framework to achieve precise, nonthermal disruption of the native fentanyl-μOR complex. Our approach exploits resonant terahertz (THz) near-fields to deliver a Stark perturbation phase-locked to the dominant reaction coordinates: the Asp147 salt-bridge stretch and the His297 hydrogen-bond stretch. The model combines anharmonic Morse potentials for bond stretching with a quantum hindered rotor for ligand torsion, yielding a time-dependent Schrödinger equation with analytic matrix elements. This formalism captures the critical interplay between linear (dipolar) and quadratic (polarizability) Stark effects, which transiently lower the dissociation barrier. We predict dissociation kinetics as a function of field amplitude, frequency, orientation, and pulse duty cycle, establishing a scalable and testable platform for an electromagnetic antidote.

Indexed as

Analgesics, OpioidFentanylOpiate OverdoseReceptors, Opioid, muBinding SitesHumansHydrogen BondingKineticsModels, MolecularProtein BindingAnalgesics, OpioidFentanylReceptors, Opioid, muBioelectromagneticsFentanyl-μ-opioid receptorOpioid pharmacodynamicsTerahertz-induced disruption

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.